1-20 of 21
Howard Streicher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2)

Jessica M. Stempel, Geoffrey L. Uy, Shira N. Dinner, Ivana Gojo, Daniel Reed, Rupali Roy, Kenneth P Byrd, Swaroopa Yerrabothala, Catherine E. Lai, Kimberley Doucette, Anne Caldwell, Ondrej Blaha, Nikolai A. Podoltsev, Lourdes M Mendez, Jan Philipp Bewersdorf, Tariq Kewan, Ignacio Wistuba, Gheath Alatrash, Cara L Haymaker, Howard Streicher, Elad Sharon, Richard Little, Steven D. Gore, Jerald P. Radich, Brent L. Wood, Amer M. Zeidan, Rory M. Shallis
Journal: Blood
Blood (2024) 144 (Supplement 1): 736.
https://doi.org/10.1182/blood-2024-210370
Published: 2024
Journal Articles

Blinatumomab in Combination with Immune Checkpoint Inhibitors (ICIs) of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Results of a Phase I Study

Jonathan Allen Webster, Marlise R. Luskin, Joseph Rimando, Amanda Blackford, Amer M. Zeidan, Elad Sharon, Howard Streicher, Daniel J. DeAngelo, Leo Luznik, Ivana Gojo
Journal: Blood
Blood (2023) 142 (Supplement 1): 966.
https://doi.org/10.1182/blood-2023-191109
Published: 2023
Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Clinical Trials & Observations
Jacqueline S. Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K. Tomlinson, Lourdes M. Mendez, Paul Koller, Nicole Cullen, Yohei Arihara, Kathleen Pfaff, Jacquelyn O. Wolff, Andrew M. Brunner, Ilene Galinsky, Asad Bashey, Joseph H. Antin, Corey Cutler, Vincent Ho, Brian A. Jonas, Marlise R. Luskin, Martha Wadleigh, Eric S. Winer, Alexandra Savell, Rebecca Leonard, Taylor Robertson, Matthew S. Davids, Howard Streicher, Scott J. Rodig, Jerome Ritz, Catherine J. Wu, Daniel J. DeAngelo, Donna Neuberg, Richard M. Stone, Robert J. Soiffer
Journal: Blood
Blood (2023) 141 (15): 1884–1888.
https://doi.org/10.1182/blood.2022017686
Published: 2023
Includes: Supplemental data
Journal Articles

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Clinical Trials & Observations
Livius Penter, Yang Liu, Jacquelyn O. Wolff, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Nicole M. Cullen, Kathleen L. Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Elizabeth A. Morgan, Helen X. Chen, Minkyung H. Song, Magdalena Thurin, Shuqiang Li, Scott J. Rodig, Carrie Cibulskis, Stacey Gabriel, Pavan Bachireddy, Jerome Ritz, Howard Streicher, Donna S. Neuberg, F. Stephen Hodi, Matthew S. Davids, Sacha Gnjatic, Kenneth J. Livak, Jennifer Altreuter, Franziska Michor, Robert J. Soiffer, Jacqueline S. Garcia, Catherine J. Wu
Journal: Blood
Blood (2023) 141 (15): 1817–1830.
https://doi.org/10.1182/blood.2022018246
Published: 2023
Includes: Supplemental data
Journal Articles

Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS

Livius Penter, Yang Liu, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Jacquelyn Wolff, Nicole Cullen, Kathleen Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Helen Chen, Magdalena Thurin, Shuqiang Li, Scott J. Rodig, Carrie Cibulskis, Stacey Gabriel, Jerome Ritz, Howard Streicher, Donna S. Neuberg, Stephen Hodi, Sacha Gnjatic, Kenneth J Livak, Jennifer Altreuter, Franziska Michor, Robert J Soiffer, Jacqueline S. Garcia, Catherine J. Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10198–10199.
https://doi.org/10.1182/blood-2022-157339
Published: 2022
Journal Articles

Randomized Phase II Study to Assess the Role of Nivolumab As Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients after Chemotherapy (NCI9706 protocol; REMAIN Trial)

Hongtao Liu, Elad Sharon, Theodore G. Karrison, Yuanyuan Zha, Noreen Fulton, Howard Streicher, Kendra Sweet, George Yaghmour, Jane Jijun Liu, Brian A. Jonas, Aaron D. Schimmer, Steven Grant, Amer M. Zeidan, Gerhard C. Hildebrandt, Christopher S. Hourigan, Christopher H. Lowrey, Ryan J. Mattison, Neil Palmisiano, Amandeep Salhotra, Dimitrios Tzachanis, Maria R. Baer, Tara L. Lin, Prapti Patel, Helen Chen, Walter M. Stadler, Olatoyosi Odenike, Richard A. Larson, Thomas F. Gajewski, Wendy Stock
Journal: Blood
Blood (2022) 140 (Supplement 1): 1716–1719.
https://doi.org/10.1182/blood-2022-157326
Published: 2022
Journal Articles

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Clinical Trials & Observations Brief Report
Livius Penter, Yi Zhang, Alexandra Savell, Teddy Huang, Nicoletta Cieri, Emily M. Thrash, Seunghee Kim-Schulze, Aashna Jhaveri, Jingxin Fu, Srinika Ranasinghe, Shuqiang Li, Wandi Zhang, Emma S. Hathaway, Matthew Nazzaro, Haesook T. Kim, Helen Chen, Magdalena Thurin, Scott J. Rodig, Mariano Severgnini, Carrie Cibulskis, Stacey Gabriel, Kenneth J. Livak, Corey Cutler, Joseph H. Antin, Sarah Nikiforow, John Koreth, Vincent T. Ho, Philippe Armand, Jerome Ritz, Howard Streicher, Donna Neuberg, F. Stephen Hodi, Sacha Gnjatic, Robert J. Soiffer, X. Shirley Liu, Matthew S. Davids, Pavan Bachireddy, Catherine J. Wu
Journal: Blood
Blood (2021) 137 (23): 3212–3217.
https://doi.org/10.1182/blood.2021010867
Published: 2021
Includes: Supplemental data
Journal Articles

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Clinical Trials & Observations
Matthew S. Davids, Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo O. Maegawa, Alexandra Savell, Michael Mazzeo, Adrienne Anderson, Alexander P. Boardman, Augustine Weber, David Avigan, Yi-Bin Chen, Sarah Nikiforow, Vincent T. Ho, Corey Cutler, Edwin P. Alyea, Pavan Bachireddy, Catherine J. Wu, Jerome Ritz, Howard Streicher, Edward D. Ball, Asad Bashey, Robert J. Soiffer, Philippe Armand
Journal: Blood
Blood (2020) 135 (24): 2182–2191.
https://doi.org/10.1182/blood.2019004710
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Naïve Patients with Relapsed or Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multi-Center Phase 1, Two-Arm, Dose-Escalation Study

Jacqueline S Garcia, MD, Lillian Werner, Benjamin K. Tomlinson, MD, Michael Keng, MD, Myrna Nahas, MD, Andrew Brunner, MD, Samer K. Khaled, MD, Alexandra Savell, BS, Marlise Luskin, MDMS, David P. Steensma, MD, Martha Wadleigh, MD, Eric S. Winer, MD, Edwin P. Alyea, III, MD, Corey Cutler, MD MPH, FRCPC, Vincent T. Ho, MD, Donna S Neuberg, ScD, Nicole Cullen, Andreas Kantartzis, Ana Lako, Scott Rodig, MD PhD, R. Coleman Lindsley, MD PhD, Yael Flamand, Claire Manuszak, Ryan Brennick, Mariano Severgnini, Stephanie Andrews, Ilene Galinsky, Pavan Bachireddy, MD, Yohei Arihara, MD PhD, Jerome Ritz, MD, Matthew S. Davids, MD, Howard Streicher, MD, Catherine J. Wu, MD, Richard M. Stone, MD, Daniel J. DeAngelo, MD, Robert J. Soiffer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2015.
https://doi.org/10.1182/blood-2019-126238
Published: 2019
Journal Articles

Effective Immunomodulation with Pomalidomide Beginning at Early Lymphocyte Recovery during Induction Timed Sequential Therapy (TST) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplasia (HR-MDS)

Joshua F Zeidner, MD, Hanna Knaus, MD, Amer M. Zeidan, MBBS, MHS, Amanda Blackford, Raul Montiel-Esparza, MD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MD PhD, Gabriel Ghiaur, MD PhD, Margaret M. Showel, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, B. Douglas Smith, MD, Mark J. Levis, MD, Matthew C Foster, MD, Catherine C. Coombs, MD, Howard Streicher, MD, Judith E. Karp, MD, Leo Luznik, MD, Ivana Gojo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 335.
https://doi.org/10.1182/blood-2018-99-114961
Published: 2018
Journal Articles

A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Matthew S. Davids, MD, Haesook T. Kim, PhD, Caitlin L. Costello, MD, Alex F. Herrera, MD, Frederick L. Locke, MD, Rodrigo O. Maegawa, MD, Alexandra Savell, BS, Michael Mazzeo, BA, David E. Avigan, MD, Yi-Bin Chen, MD, Sarah Nikiforow, MD PhD, Vincent T. Ho, MD, Corey S. Cutler, MD MPH, Edwin P. Alyea, III, MD, Pavan Bachireddy, MD, Catherine J. Wu, MD, Howard Streicher, MD, Edward D Ball, MD, Asad Bashey, MD PhD, Robert J. Soiffer, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 705.
https://doi.org/10.1182/blood-2018-99-117671
Published: 2018
Journal Articles

Blinatumomab in Combination with Immune Checkpoint Inhibitors of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Preliminary Results of a Phase I Study

Jonathan Webster, MD, Marlise R. Luskin, MD, Gabrielle T. Prince, MD, Amy E. DeZern, MD, Daniel J. DeAngelo, MD, Mark J. Levis, MD, Amanda Blackford, Elad Sharon, MD MPH, Howard Streicher, MD, Leo Luznik, MD, Ivana Gojo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 557.
https://doi.org/10.1182/blood-2018-99-111845
Published: 2018
Journal Articles

Optimizing Checkpoint Blockade As a Treatment for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

Matthew S. Davids, MD, Haesook T Kim, PhD, Caitlin Costello, MD, Alex F. Herrera, MD, Frederick L. Locke, MD, Peter McSweeney, MD, Rodrigo O. Maegawa, MD, Alexandra Savell, BS, Michael Mazzeo, BA, David E. Avigan, MD, Yi-Bin Chen, MD, Nicole R. LeBoeuf, MD MPH, Vincent T Ho, MD, Corey S. Cutler, MD MPH, John Koreth, MBBS, DPhil, Edwin Alyea, III, MD, Joseph H. Antin, MD, Pavan Bachireddy, MD, Catherine J. Wu, MD, Jerome Ritz, MD, Howard Streicher, MD, Edward D Ball, MD, Asad Bashey, MD PhD, Philippe Armand, MD PhD, Robert J. Soiffer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 275.
https://doi.org/10.1182/blood.V130.Suppl_1.275.275
Published: 2017
Journal Articles

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Tara M. Robinson, MD PhD, Hanna Knaus, MD, B Douglas Smith, MD, Andrea M.H. Towlerton, BS, Edus H. Warren, III, MDPhD, Joshua F Zeidner, MD, Amanda Blackford, Amy S. Duffield, MD PhD, David Rizzieri, MD, Mark G. Frattini, MD PhD, Moshe Levy, MD, Mark A. Schroeder, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1699.
https://doi.org/10.1182/blood.V130.Suppl_1.1699.1699
Published: 2017
Journal Articles

Checking up on checkpoint inhibitors

Richard F. Little, Howard Streicher
Journal: Blood
Blood (2017) 130 (2): 107–108.
https://doi.org/10.1182/blood-2017-05-783696
Published: 2017
Journal Articles

Phase 1 Study of Pomalidomide Given at the Time of Early Lymphocyte Recovery after Induction Timed Sequential Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS)

Joshua F. Zeidner, MD, Raul Montiel-Esparza, MD, Hanna A. Knaus, MD, Sofia Berglund, MD PhD, Amer M. Zeidan, MBBS, MHS, Shannon R. McCurdy, MD, Gabrielle T Prince, MD, Lukasz P Gondek, MD PhD, Gabriel Ghiaur, MD PhD, Margaret M. Showel, MD, Amy E. DeZern, MD MHS, Keith W. Pratz, MD, B. Douglas Smith, MD, Mark J. Levis, MD PhD, Matthew C Foster, MD, Katarzyna Jamieson, MD, Hendrik W. Van Deventer, MD, Howard Streicher, MD, Judith E. Karp, MD, Leo Luznik, MD, Ivana Gojo, MD
Journal: Blood
Blood (2016) 128 (22): 2820.
https://doi.org/10.1182/blood.V128.22.2820.2820
Published: 2016
Journal Articles

Stabilization of Myelodysplastic Syndromes (MDS) Following Hypomethylating Agent (HMAs) Failure Using the Immune Checkpoint Inhibitor Ipilimumab: A Phase I Trial

Amer M. Zeidan, MBBS, MHS, Joshua F. Zeidner, MD, Amy Duffield, MD, Hanna A. Knaus, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD MHS, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, B. Douglas Smith
Journal: Blood
Blood (2015) 126 (23): 1666.
https://doi.org/10.1182/blood.V126.23.1666.1666
Published: 2015
Journal Articles

Immune Modulation with Pomalidomide after Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Raúl Montiel-Esparza, MD, Hanna A. Knaus, MD, Joshua F. Zeidner, MD, Ante Vulic, MD, Gabrielle T. Prince, MD, B. Douglas Smith, MD, Mark J. Levis, MD PhD, Howard Streicher, MD, Judith E. Karp, MD, Leo Luznik, MD, Ivana Gojo, MD
Journal: Blood
Blood (2015) 126 (23): 1351.
https://doi.org/10.1182/blood.V126.23.1351.1351
Published: 2015
Journal Articles

Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, Ewa Carrier, MD, Linda Vrooman, RN, Howard Streicher, MD, Israel Lowy, MD, Scott R. Solomon, MD, Lawrence E. Morris, MD, Kent Holland, MD, James R. Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD
Journal: Blood
Blood (2007) 110 (11): 1646.
https://doi.org/10.1182/blood.V110.11.1646.1646
Published: 2007
Journal Articles

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, RN, Ewa Carrier, MD, Howard Streicher, MD, Israel Lowy, MD, James R. Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD
Journal: Blood
Blood (2006) 108 (11): 410.
https://doi.org/10.1182/blood.V108.11.410.410
Published: 2006